CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

November 19, 2026 · Acquisition

CMMB Acquisition: a negative outcome, -26.5%

On November 19, 2026, Chemomab Therapeutics Ltd. reached its Acquisition. The result was a negative outcome, and the stock moved -26.5% in the window around the event. It had already run +37.3% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.

The move

$1.55
1d before
$1.14
Event day
$1.19
1d after
$1.19
5d after

Pre-catalyst setup

+37.3%
30-day run-up
6514%
30-day volatility
0.6×
volume spike